JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lorberboym, M.
Right arrow Articles by Lampl, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lorberboym, M.
Right arrow Articles by Lampl, Y.

123I-FP-CIT SPECT Imaging of Dopamine Transporters in Patients with Cerebrovascular Disease and Clinical Diagnosis of Vascular Parkinsonism

Mordechai Lorberboym, MD1,2, Ruth Djaldetti, MD2,3, Eldad Melamed, MD2,3, Menahem Sadeh, MD2,4 and Yair Lampl, MD2,4

1 Department of Nuclear Medicine, Edith Wolfson Medical Center, Holon, Israel
2 Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
3 Department of Neurology, Rabin Medical Center, Petah Tiqva, Israel
4 Department of Neurology, Edith Wolfson Medical Center, Holon, Israel



View larger version (54K):

[in a new window]
 
FIGURE 1. Illustration of region-of-interest placement on caudate and putamen.

 


View larger version (14K):

[in a new window]
 
FIGURE 2. 123I-FP-CIT binding in different striatal regions in patients with good response and in patients with poor response to L-dopa therapy. ASGR = abnormal study with good response; ASPR = abnormal study with poor response; NSPR = normal study with poor response; SR = right striatum; SL = left striatum; CR = right caudate; CL = left caudate; PR = right putamen; PL = left putamen; P/C R = putamen-to-caudate ratio on right; P/C L = putamen-to-caudate ratio on left.

 


View larger version (56K):

[in a new window]
 
FIGURE 3. 123I-FP-CIT SPECT of 5 patients with good response to therapy (upper row: left, middle, and right; and lower row: left and middle) and patient with poor response to therapy (lower row: right; patient 7).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.